Gut Bacteria May Signal Early Risk of Parkinson’s Disease
Recent research indicates that specific bacteria in our gut might reveal the risk of developing Parkinson’s disease well before any symptoms show. A study led by researchers at University College London (UCL) examined the gut microbes of 271 individuals diagnosed with Parkinson’s in the U.K.
The study also included 43 people with the GBA1 gene variant, known to raise the likelihood of developing Parkinson’s by nearly 30 times, though these participants showed no symptoms. Additionally, 150 healthy individuals without the gene were part of the control group.
According to findings, over 25% of gut microbes were present in different amounts in patients with Parkinson’s compared to healthy participants. Interestingly, those carrying the Parkinson’s gene but not yet showing symptoms had microbial changes hinting at an “intermediate” stage of the disease, hinting that these changes could occur before symptoms develop.
Research showed that individuals who consumed a more varied and balanced diet had less likelihood of exhibiting gut microbiome patterns associated with an increased risk of Parkinson’s. The study, published in Nature Medicine, involved more than 1,400 participants from the U.K., South Korea, and Turkey, suggesting that these microbial changes are consistent across different diets and cultures.
Dr. Earnest Lee Murray, a neurologist, pointed out that patients with Parkinson’s often experience significant gut issues, including constipation, long before other symptoms appear. He emphasized the importance of studies like this in light of the rising prevalence of Parkinson’s, especially as the aging population continues to grow.
Experts believe that understanding the gut-brain connection might eventually lead to earlier treatments aimed at preventing or delaying the onset of Parkinson’s. However, researchers caution that their study cannot conclusively state that changes in the microbiome directly cause Parkinson’s, as other genetic and environmental factors may also play a role.
While this research opens the door to possibilities of early detection and intervention, the need for deeper studies continues. The findings were made possible through the support of organizations like the Michael J. Fox Foundation for Parkinson’s Research and the UK Medical Research Council.
As the search for effective treatments continues, researchers stress the importance of identifying those at risk as early as possible.
